CAS 945667-22-1 Ubunyulu > 99.0% (HPLC) API
Ruifu Chemical Supply Related Intermediates
I-CAS 361442-04-8
I-CAS 945667-22-1
(R)-1-Boc-3-Aminopiperidine CAS 188111-79-7
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
I-Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4
(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo [3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester CAS 361440-67-7
I-2-(3-Hydroxy-1-Adamantyl)-2-Oxoacetic Acid CAS 709031-28-7
Izithethantonye | I-BMS-477118 Hydrate;I-Onglyza Hydrate;(1S,3S,5S)-2-[(2S)-2-Amino-2-(3-Hydroxy-1-Adamantyl)acetyl]-2-Azabicyclo [3.1.0]hexane-3-Carbonitrile Hydrate;(1S,3S,5S)-2-[(S)-2-Amino-2-[(1r,3R,5R,7S)-3-Hydroxyadamantan-1-yl]acetyl]-2-Azabicyclo [3.1.0 ]hexane-3-Carbonitrile Hydrate |
Inombolo yeCAS | 945667-22-1 |
Inombolo yeCAT | RF-PI1992 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | C18H25N3O2·H2O |
Ubunzima beMolekyuli | 333.43 |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo oMhlophe |
ukuchongwa | A: IR B: Ixesha lokugcinwa kweHPLC |
Ubunyulu / Indlela yokuHlalutya | >99.0% (HPLC, Kwisiseko Esomileyo) |
Isiqulatho samanzi (KF) | 5.3%~7.3% |
Intsalela kwi-Ignition | <0.20% |
Ukungacoceki Okukodwa | <0.50% |
Ukungcola ngokupheleleyo | <1.00% |
Iintsimbi ezinzima | <10ppm |
IArsenic (As) | <2ppm |
IMicrobiology | |
Ukubalwa kwePleti iyonke | <1000cfu/g |
Igwele kunye noMngundo | <100cfu/g |
E. Coli | Ibi |
S. Aureus | Ibi |
Salmonella | Ibi |
Beka ubomi kwishelufa | Iinyanga ezingama-24 |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | API;Isetyenziselwa uNyango lweSifo seswekile sesibini |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma
I-API (i-CAS: i-945667-22-1) yi-inhibitor ekhethiweyo kunye ne-reversible dipeptidyl peptidase-4 (DPP4) engasetyenziselwa ukuphuhlisa unyango lwe-2 yeswekile.Yi-inhibitor ye-DPP4 ekhethiweyo kunye ne-reversible kunye ne-IC50 ye-26 nM kunye ne-Ki ye-1.3 nM.IC50 ixabiso: 26 nM.Ithagethi: DPP4 in vitro: Ine-inhibition constant Ki ye-1.3 nM ye-DPP4 inhibition, ephindwe ka-10 ngamandla kune-Sitagliptin (enye i-DPP4 inhibitors ezimbini) ene-Ki ye-13 kunye ne-18 nM.Ukongeza, Ibonisa ukucaciswa okukhulu kwe-DPP4 kunokuba i-DPP8 okanye i-DPP9 enzymes (400- kunye ne-75-fold, ngokulandelanayo).Imetablite esebenzayo yayo iphindwe kabini ingaphantsi ngamandla kunomzali.Bobabini (i-CAS: i-945667-22-1) kunye ne-metabolite yayo ikhetha kakhulu (> I-4000-fold) yokukhusela i-DPP4 xa kuthelekiswa noluhlu lwezinye iiproteases.(CAS: 945667-22-1) inciphisa ukuthotywa kwe-incretin hormone glucagon-like peptide-1, ngaloo ndlela iphucula izenzo zayo, kwaye inxulunyaniswa nomsebenzi ophuculweyo we-β-cell kunye nokunyanzeliswa kwe-glucagon secretion.in vivo: Isebenza kakhulu. ekufuneni ukuphuculwa kwedosi ephawulweyo kwi-glucose clearance kwi-dose range 0.13-1.3 mg/kg kwi-ob/ob mice ngokumalunga nolawulo.